Proposed Experimental Treatment Access Trust Fund
March 13, 2026
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
The Frame
The bill establishes a dedicated funding mechanism to assist patients with the high costs of accessing experimental medical procedures, contingent upon the passage of related legislation.
Potentially affected actors named in the source documents. Mention is not a position.
Florida residents
Patients seeking experimental treatments may receive financial assistance for travel and care costs.
Licensed experimental treatment centers
These facilities must either contribute 2% of net annual profits to the fund or provide an equivalent value in free care.
Department of Health
The department is responsible for managing the fund and adopting rules for center contributions.
Last recorded activity March 13, 2026.
Introduced.
Background
- SB 1556 was introduced during the 2026 legislative session but failed to advance out of the Health Policy committee. context
Summary
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
Who is eligible for assistance from this fund?
How is the fund paid for?
When does the fund expire?
Why It Matters
The bill establishes a dedicated funding mechanism to assist patients with the high costs of accessing experimental medical procedures, contingent upon the passage of related legislation.
News Coverage
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Contingent Legislation Requirement
The bill's implementation is explicitly tied to the passage of other, unnamed legislation, creating a dependency that prevents it from functioning as a standalone policy.
Connected Entities
Sources
openstates.org
Analysis Score
0–100- Significance45How much this matters to a regular citizen
- Controversy20Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz10Current news / social attention level
Publisher tools